Volume 53, Issue 4, Pages (April 1998)

Slides:



Advertisements
Similar presentations
Management of IgA nephropathy: Evidence-based recommendations
Advertisements

E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P
Plasma sodium and hypertension
Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction 
Volume 70, Issue 8, Pages (October 2006)
Viper venom for diabetic nephropathy
Anemia management in chronic kidney disease
Volume 56, Pages S95-S98 (November 1999)
Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani 
Membranous nephropathy: When and how to treat
Viper venom for diabetic nephropathy
Volume 61, Issue 4, Pages (April 2002)
Dieter A. Häberle, Wolfgang Biller, Takuyuki Ise, Christian J. Metz 
Volume 53, Issue 4, Pages (April 1998)
Volume 54, Issue 6, Pages (January 1998)
Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.
Volume 80, Issue 9, Pages (November 2011)
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
Volume 63, Issue 2, Pages (February 2003)
Prediction of hypertension in chronic hemodialysis patients
Proinflammatory effects of iron sucrose in chronic kidney disease
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Body weight is a fluctuating parameter in hemodialysis patients
Nephrology Crosswords: Hemodialysis
Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension  A. Davenport, C. Cox, R. Thuraisingham  Kidney.
Volume 66, Issue 1, Pages (July 2004)
Gentamicin pharmacokinetics during slow daily home hemodialysis
Blood pressure targets in hemodialysis patients
Volume 69, Issue 10, Pages (May 2006)
Volume 67, Issue 1, Pages (January 2005)
Volume 67, Issue 1, Pages (January 2005)
Volume 61, Issue 6, Pages (June 2002)
Volume 53, Issue 4, Pages (April 1998)
Volume 67, Issue 1, Pages (January 2005)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 85, Issue 5, Pages (May 2014)
Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower 
Volume 73, Issue 10, Pages (May 2008)
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
The kidney, a cardiovascular risk marker, and a new target for therapy
Volume 61, Issue 1, Pages (January 2002)
Counteracting progression of renal disease: A look into the future
Circadian regulation of renal function
A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related.
Volume 57, Issue 2, Pages (October 2000)
Daily nocturnal home hemodialysis
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
Carmine Zoccali, Francesca Mallamaci  Kidney International 
The course of the remnant kidney model in mice
Volume 53, Issue 6, Pages (June 1998)
Organ transplantation goes to the movies
Volume 63, Issue 4, Pages (April 2003)
Volume 80, Issue 10, Pages (November 2011)
Is it the low-protein diet or simply the salt restriction?
Volume 57, Issue 3, Pages (March 2000)
Volume 64, Issue 4, Pages (October 2003)
Bradley A. Warady, Mwaffek Bashir, Lynn A. Donaldson 
Importance of blood pressure control in hemodialysis patient survival
Volume 68, Issue 1, Pages (July 2005)
Kathryn J. Wiggins, Darren J. Kelly  Kidney International 
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications 
Angiotensin I-Converting Enzyme
Volume 81, Issue 11, Pages (June 2012)
Volume 55, Issue 3, Pages (March 1999)
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Rebound kinetics of β2-microglobulin after hemodialysis
Quantitative estimation of renal blood flow by power Doppler ultrasonography in renovascular hypertensive dogs  Tetsumasa Miyajima, Hiroshi Yokoyama,
Antonio Piccoli, Luana Pillon  Kidney International 
Presentation transcript:

Volume 53, Issue 4, Pages 1026-1035 (April 1998) Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose- dependent and mediated by bradykinin  Detlef H. Krieter, Dr, Matthias Grude, Horst-Dieter Lemke, Edwin Fink, Gerd Bönner, Bernward A. Schölkens, Egbert Schulz, Gerhard A. Müller  Kidney International  Volume 53, Issue 4, Pages 1026-1035 (April 1998) DOI: 10.1111/j.1523-1755.1998.00837.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Systolic blood pressure (♦) and heart rate () during 60 minutes of hemodialysis. Data are mean values ±SD of six sheep. (A) Group AN/0; (B) group AN/10; (C) group AN/20; (D) group AN/30; (E) group AN/BA; (F) group PA/0; (G) group PA/20; (H) group SP/20. *P < 0.05 versus 0 minutes, **P < 0.05 versus -5 minutes. Kidney International 1998 53, 1026-1035DOI: (10.1111/j.1523-1755.1998.00837.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Ventilation rate of all groups during 60 minutes of hemodialysis. Data are mean values of six sheep. *P < 0.05 versus 0 minutes; **P < 0.05 versus 15 minutes; ***P < 0.05 versus prior to icatibant application. Kidney International 1998 53, 1026-1035DOI: (10.1111/j.1523-1755.1998.00837.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Angiotensin converting enzyme (ACE) activity of all groups before hemodialysis. Data are mean values ±SD of six sheep. *P < 0.05 versus group AN/0 and PA/0 (without ACE inhibition); **P < 0.05 versus group AN/10; ***P < 0.05 versus group AN/20. Kidney International 1998 53, 1026-1035DOI: (10.1111/j.1523-1755.1998.00837.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 Bradykinin concentrations of all groups before (front columns) and after (rear columns) passage through the dialyzer during 60 minutes of hemodialysis. Data are mean values of six sheep. *P < 0.05 versus 0 minutes. Kidney International 1998 53, 1026-1035DOI: (10.1111/j.1523-1755.1998.00837.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Bradykinin concentrations in plasma samples obtained from the carotid artery of group AN/0 (AN69 without ACE inhibition; ♦) and group AN/20 (AN69 with 20 mg enalapril; □) during 60 minutes of hemodialysis. Data are mean values ±SD. Kidney International 1998 53, 1026-1035DOI: (10.1111/j.1523-1755.1998.00837.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 6 Prekallikrein concentrations of groups AN/0, AN/10, AN/20, AN/30, PA/0, and SP/20 during 60 minutes of hemodialysis. Data are mean values ±SD of six sheep. Symbols are: (▪) 0 min; () 15 min; () 60 min. *P < 0.05 versus 0 minutes. Kidney International 1998 53, 1026-1035DOI: (10.1111/j.1523-1755.1998.00837.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 7 High molecular weight kininogen concentrations of groups AN/0, AN/10, AN/20, AN/30, PA/0, and SP/20 during 60 minutes of hemodialysis. Symbols are: (▪) 0 min; () 15 min; () 60 min. Data are mean values ±SD of six sheep.*P < 0.05 versus 0 minutes. Kidney International 1998 53, 1026-1035DOI: (10.1111/j.1523-1755.1998.00837.x) Copyright © 1998 International Society of Nephrology Terms and Conditions